Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
View Top Employees from PepGenWebsite | http://pepgen.com |
Ticker | PEPG |
Revenue | $6.6 million |
Funding | $56.2 million |
Employees | 73 (59 on RocketReach) |
Founded | 2018 |
Address | 321 Harrison Ave 8th Floor, Boston, Massachusetts 02118, US |
Phone | (781) 797-0979 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Biotechnology, Medical Devices & Equipment, Manufacturing, Pharmaceuticals, Chemistry, Biology, Bioscience, Life sciences, Therapeutics |
Competitors | Aptinyx Inc., Cala Health, Neurotech Usa Inc, NewBiotics, Protara Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 33 Companies |
Looking for a particular PepGen employee's phone or email?
The PepGen annual revenue was $6.6 million in 2024.
James McArthur is the CEO of PepGen.
59 people are employed at PepGen.
PepGen is based in Boston, Massachusetts.
The NAICS codes for PepGen are [541, 54, 33].
The SIC codes for PepGen are [87, 873].